Evidence map›Paper›PMID 34903824›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2022

Correction to: Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group.

Rashmi Kanagal-Shamanna, Attilio Orazi, Robert P Hasserjian, Daniel A Arber, Kaaren Reichard, Eric D Hsi, Adam Bagg, Heesun Joyce Rogers, Julia Geyer, Faezeh Darbaniyan and 13 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Rashmi Kanagal-ShamannaThe University of Texas MD Anderson Cancer Center, Houston, TX, USA. RKanagal@mdanderson.org.ORCID http://orcid.org/0000-0001-7829-5249
Attilio OraziTexas Tech University Health Science Center, El Paso, TX, USA.
Robert P HasserjianMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7753-0697
Daniel A ArberUniversity of Chicago, Chicago, IL, USA.
Kaaren ReichardMayo Clinic, Rochester, MN, USA.
Eric D HsiWake Forest Baptist Health, Winston-Salem, NC, USA.ORCID http://orcid.org/0000-0001-8623-4067
Adam BaggHospital of the University of Pennsylvania, Philadelphia, PA, USA.
Heesun Joyce RogersCleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0001-8491-224X
Julia GeyerWeill Cornell Medical College, New York, NY, USA.
Faezeh DarbaniyanThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kim-Anh DoThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Kyle M DevinsHospital of the University of Pennsylvania, Philadelphia, PA, USA.
Olga PozdnyakovaBrigham and Women's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8376-0344
Tracy I GeorgeUniversity of Utah, Salt Lake City, UT, USA.ORCID http://orcid.org/0000-0001-5478-7847
Paola Dal CinBrigham and Women's Hospital, Boston, MA, USA.
Patricia T GreippMayo Clinic, Rochester, MN, USA.
Mark J RoutbortThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0003-4860-261X
Keyur PatelThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-5081-2427
Guillermo Garcia-ManeroThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-3631-2482
Srdan VerstovsekThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-6912-8569
L Jeffrey MedeirosThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-6577-8006
Sa A WangThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Carlos Bueso-RamosThe University of Texas MD Anderson Cancer Center, Houston, TX, USA. cbuesora@mdanderson.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34903824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.